Time trends in the incidence of essential tremor: Evidences from UK and France primary care data.

France THIN® database United Kingdom epidemiology essential tremor

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 06 07 2022
accepted: 16 08 2022
entrez: 7 10 2022
pubmed: 8 10 2022
medline: 8 10 2022
Statut: epublish

Résumé

Although essential tremor (ET) is considered a common adult movement disorder, evidence on its incidence is still scant. This study aims at estimating ET incidence in two European countries, namely, the UK and France. Incident cases of ET were identified within the Health Improvement Network (THIN®) database between 1st January 2014 and 31 December 2019. Yearly crude and standardized incidence rates (IR) were estimated across the study period for both countries. Poisson regression models were built to assess temporal trends in IRs and differences between sexes and age classes. In total, 4,970 and 4,905 incident cases of ET were identified in the UK and France, respectively. The yearly average crude IR (per 100,000 person-years) was 18.20 (95%CI: 15.09-21.32) in UK and 21.42 (17.83-25.00) in France, whereas standardized ones were 19.51 (18.97-20.01) and 19.50 (18.97-20.05). Regression analyses showed slightly increasing trends in both countries, higher incidence among males, and a significant increase with age. Yearly average IR increased from 3.96 (0.95-6.97) and 5.28 (1.12-9.44) in subjects aged <20 years to 49.27 (26.29-72.24) and 51.52 (30.19-72.86) in those aged >80 year in UK and France. Standardized ET incidence was comparable in the UK and France, showing a slight increase in both countries, reporting a higher value among people aged 60 years and older. This study outlines the need to conduct future studies to estimate the burden of ET in terms of disease control and healthcare resource utilization.

Identifiants

pubmed: 36203992
doi: 10.3389/fneur.2022.987618
pmc: PMC9531026
doi:

Types de publication

Journal Article

Langues

eng

Pagination

987618

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 Antonazzo, Conti, Rozza, Fornari, Eteve-Pitsaer, Paris, Gantzer, Valentine, Mantovani and Mazzaglia.

Déclaration de conflit d'intérêts

Author LM has received grants and personal fees from Bayer AG, Boehringer Ingelheim, Pfizer and Daiichi-Sankyo. Authors CE-P, CP, LG, and DV are employed by Cegedim. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

N Engl J Med. 2018 Aug 09;379(6):596-597
pubmed: 30089076
Mov Disord. 2001 Sep;16(5):914-20
pubmed: 11746622
J Neurol Neurosurg Psychiatry. 1984 May;47(5):466-70
pubmed: 6736976
BMJ. 2016 Sep 23;354:i4803
pubmed: 27662893
Front Neurol. 2017 Aug 14;8:396
pubmed: 28855888
Lancet Digit Health. 2022 Mar;4(3):e169-e178
pubmed: 35216751
Mov Disord. 2018 Jan;33(1):75-87
pubmed: 29193359
Tremor Other Hyperkinet Mov (N Y). 2021 Jul 09;11:28
pubmed: 34277141
Biostatistics. 2010 Apr;11(2):373-4
pubmed: 19948745
Parkinsonism Relat Disord. 2015 Jul;21(7):729-35
pubmed: 25952960
Nat Rev Neurol. 2020 Feb;16(2):84-96
pubmed: 31900464
Mov Disord. 2008 May 15;23(7):993-997
pubmed: 18383536
Inform Prim Care. 2011;19(4):251-5
pubmed: 22828580
Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):76-83
pubmed: 19065600
Neurology. 2005 May 24;64(10):1721-5
pubmed: 15911798
BMJ Open. 2020 Jul 19;10(7):e036584
pubmed: 32690524
Lancet Neurol. 2005 Feb;4(2):100-10
pubmed: 15664542
Lancet Neurol. 2015 Jan;14(1):57-64
pubmed: 25435387
Pharmacoepidemiol Drug Saf. 2014 Feb;23(2):111-8
pubmed: 24375925
J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):423-5
pubmed: 19289477
Neurology. 2000;54(11 Suppl 4):S7
pubmed: 10854345
Mov Disord. 2007 Mar 15;22(4):540-5
pubmed: 17260338
Nat Rev Dis Primers. 2021 Nov 11;7(1):83
pubmed: 34764294
J Glob Health. 2021 Apr 10;11:04028
pubmed: 33880180

Auteurs

Ippazio Cosimo Antonazzo (IC)

Research Centre on Public Health (CESP), University of Milano-Bicocca, Monza, Italy.

Sara Conti (S)

Research Centre on Public Health (CESP), University of Milano-Bicocca, Monza, Italy.

Davide Rozza (D)

Research Centre on Public Health (CESP), University of Milano-Bicocca, Monza, Italy.

Carla Fornari (C)

Research Centre on Public Health (CESP), University of Milano-Bicocca, Monza, Italy.

Caroline Eteve-Pitsaer (C)

Cegedim, Boulogne-Billancourt, France.

Claire Paris (C)

Cegedim, Boulogne-Billancourt, France.

Laurène Gantzer (L)

Cegedim, Boulogne-Billancourt, France.

Dennis Valentine (D)

Cegedim, London, United Kingdom.

Lorenzo Giovanni Mantovani (LG)

Research Centre on Public Health (CESP), University of Milano-Bicocca, Monza, Italy.

Giampiero Mazzaglia (G)

Research Centre on Public Health (CESP), University of Milano-Bicocca, Monza, Italy.

Classifications MeSH